Dr. Emily S. Tonorezos Named Director of NCI Office of Cancer Survivorship
Emily S. Tonorezos, MD, MPH, has been appointed Director of the Office of Cancer Survivorship (OCS) at the National Cancer Institute (NCI). Part of NCI’s Division of Cancer Control and Population Sciences (DCCPS), OCS was established in 1996 in recognition of the growing number of cancer survivors and the importance of better understanding and meeting their unique needs. In this position, Dr. Tonorezos will lead NCI’s efforts to address the challenges facing cancer survivors and their families -- to prevent or mitigate adverse effects and to improve the health and well being of cancer survivors from the time of diagnosis through the remainder of their lives.
“We are very excited to welcome Dr. Tonorezos to the National Cancer Institute,” said DCCPS Director Robert Croyle, PhD. “NCI is fully committed to strengthening research on cancer survivors, and the OCS Director is uniquely positioned to provide key leadership in this important area. I also want to give special thanks to Dr. Deborah Mayer for her terrific service as Interim Director of the Office of Cancer Survivorship since the retirement of Dr. Julia Rowland.”
Dr. Tonorezos comes to NCI from Memorial Sloan Kettering Cancer Center and the Weill Cornell Medical College, both in New York, NY, where she served as Director of the Adult Long-Term Follow-Up Program for survivors of childhood and young adult cancers. Her research, which has been funded by the National Institutes of Health and by the American Cancer Society, among other organizations, focuses on cardiometabolic consequences of cancer therapy, childhood and young adult cancer survivorship, diet and nutrition, and care coordination for this population. She serves on the National Academy of Sciences, Engineering and Medicine Committee on Childhood Cancer and Disability; the Cancer Survivorship Committee, the Adolescent and Young Adult Task Force, and the Clinical Guideline Committee for the American Society of Clinical Oncology (ASCO); and the Metabolic Syndrome Guideline Committee for the Children’s Oncology Group (COG). She is currently co-leader of the International Guideline Harmonization Group for the metabolic syndrome and led a recent international effort to develop recommendations for adult survivors of heritable retinoblastoma.
Dr. Tonorezos earned her medical degree from the University of Rochester School of Medicine and masters in public health from the Johns Hopkins Bloomberg School of Public Health. She completed internal medicine residency and chief residency at Columbia University Medical Center, as well as a general internal medicine fellowship at the Johns Hopkins Hospital.
“I’m thrilled that Dr. Tonorezos will be leading our survivorship program,” said Dr. Croyle. “An exceptional clinician-scientist, she has all of the energy, scientific vision, and collaborative skills required to succeed in this challenging role.”